Modulation of human papillomavirus type 16 mRNA in cervical invasive carcinoma patients by interferon-α therapy

Journal of Interferon and Cytokine Research

Volumn 16, Issue 9, 1996, Pages 739-743

  García Milián, Rolando ^a   Rios, Maria A ^b   Amigó, Margarita ^b   Díaz, Dionisio ^b   Guilar, Orlando ^b   Silveira, Mario ^b   Araña, Manuel J ^a   Perea, Silvio E ^a,c  

^a Departamento de Biologia Celular   (Cuba)

^b INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^c NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; VIRUS DNA;

ADULT; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER REGRESSION; CASE REPORT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TOPICAL DRUG ADMINISTRATION; TUMOR BIOPSY; UTERINE CERVIX CANCER;

CANCER VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0029759539     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.739     Document Type: Article

References (18)

1. LORINEZ, A.T., TEMPLE, G.F., KURMAN, F.J., JENSON, A.B., and LANCASTER, W.D. (1987). Oncogenic association of specific human papillomavirus types with cervical neoplasia. J. Natl. Cancer Inst. 79, 671-677.
2. SHIRAWASA, H., TOMITA, Y., SEKIYA, S., TAKAMIZAWA, H., and SIMIZU, B. (1987). Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J. Gen. Virol. 68, 583-591.
3. VON KNEBEL DOEBERITZ, M., OLTERSDORF, T., SCHWARZ, E., and GISSMANN. L. (1988). Correlation of modified human papillomavirus early gene expression with altered growth properties of C4-1 cervical carcinoma cells. Cancer Res. 48, 3780-3786.
4. WOODWORTH, C.D., LICHTI, U., SIIMPSON, S., EVANS, CH. H., and DIPAOLO, J. (1992). Leukoregulin and gamma interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res. 52, 456-463.
5. DE MARCO, F., and MARCANTE, M.L. (1993). HPV-16 E6-E7 differential transcription induced in SiHa cervical cancer cell line by interferon. J. Biol. Regul. Homeo. Agents 7, 15-21.
6. LOPEZ-OCEJO, O., PEREA, S.E., REYES, A., VIGOA, L., and LOPEZ-SAURA, P. (1993). Partial phenotype reversion of HeLa cells by long-term interferon alfa treatment. J. Interferon Res. 13, 369-375.
7. PEREA, S.E., LOPEZ-OCEJO, O., GARCIA-MILIAN, R., and ARAÑA, M.J. (1995). Alpha interferon elicits down-regulation of human papillomavirus 18 (HPV-18) mRNA on HeLa cells by selective repression of endogenous viral transcription. J. Interferon Cytokine Res. 15, 495-501.
8. HAGLUND, S., LUNDQUIST, P.O., CANTELL, K., and STRANDER, H. (1985). Interferon therapy in juvenile laryngeal papillomatosis. Arch. Otolaryngol. 107, 327-332.
9. BORNSTEIN, J., BEN-DAVID, Y., ATAD, J., PASCAL, B., REVEL, M., and ABRAMOVICI, H. (1993). Treatment of cervi-cal intraepithelial neoplasia and invasive squamous cell carcinoma by interferon. Obstet. Gynecol. Surv. 48, 251-260.
10. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
11. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
12. FEINBERG, A.P., and VOGELSTEIN, B. (1983). A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
13. MITRANI-ROSENBAUM, S., TSVIELI, R., and TUR-KASPA, R. (1989). Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J. Gen. Virol. 70, 2227-2232.
14. SMOTKIN, D., and WETTSTEIN, F.O. (1986). Transcription of human papillomavirus type 16 early genes in a cervical and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83, 4680-4684.
15. SCHWARZ, E., FREESE, U.K., GISSMANN, L., MAYER, W., ROGGENBUCK, B., STREMLAU, A., and ZUR HAUSEN, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
16. LIPPMAN, S.M., KAVANAGH, J.J., PAREDES-ESPINOSA, M., DELGADILLO-MADRUEÑO, F., PAREDES-CASILLAS. P., KI HONG, W., HOLDENER, E., and KRAKOFF, I.H. (1992). 13-cis-Retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst. 84, 241-245.
17. TUREK, L.P., BYRNE, J.C., and LOWY, D.R. (1982). Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc. Natl. Acad. Sci. USA 79, 7914-7918.
18. SEN, G.C., and LENGYEL, P. (1992). The interferon system - a bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020.